60¢sixtycents

Merck & Co., Inc.MRK

$113.87-1.57 (-1.36%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$281B
Mega-cap
+87%
2016 — today
10-Year Price
+112%
2016 — today
52-Week Range
$77.60$123.93
Current $113.87· 78%

Merck & Co. operates through two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment develops medicines and vaccines for oncology, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment provides veterinary medications, vaccines, and digital solutions for identification and monitoring. Serving wholesalers, hospitals, and veterinarians, Merck maintains strategic collaborations with AstraZeneca, Bayer, Eisai, and Gilead for HIV therapy development. Established in 1891.

Valuation in context

P/E ratio
32.1
Above average
Pricier than usual over the last 10 years
P/B ratio
6.1
Above average
Pricier than usual over the last 10 years
EV / EBITDA
17.3
Above average
Pricier than usual over the last 10 years
Dividend Yield
3.0%
Around average
Around the 10-year average
PEG ratio
6.3
Historically pricey
Historically pricey — last 10 years
FCF Yield
5.0%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when MRK is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.